163 related articles for article (PubMed ID: 3013816)
1. Clinical study of the radioprotective effects of Amifostine (YM-08310, WR-2721) on chronic radiation injury.
Takahashi I; Nagai T; Miyaishi K; Maehara Y; Niibe H
Int J Radiat Oncol Biol Phys; 1986 Jun; 12(6):935-8. PubMed ID: 3013816
[TBL] [Abstract][Full Text] [Related]
2. Changes in salivary gland function after radiotherapy of head and neck tumors measured by quantitative pertechnetate scintigraphy: comparison of intensity-modulated radiotherapy and conventional radiation therapy with and without Amifostine.
Münter MW; Hoffner S; Hof H; Herfarth KK; Haberkorn U; Rudat V; Huber P; Debus J; Karger CP
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):651-9. PubMed ID: 17175118
[TBL] [Abstract][Full Text] [Related]
3. The effect of amifostine or IMRT to preserve the parotid function after radiotherapy of the head and neck region measured by quantitative salivary gland scintigraphy.
Rudat V; Münter M; Rades D; Grötz KA; Bajrovic A; Haberkorn U; Brenner W; Debus J
Radiother Oncol; 2008 Oct; 89(1):71-80. PubMed ID: 18707782
[TBL] [Abstract][Full Text] [Related]
4. Scintigraphic assessment of salivary function and excretion response in radiation-induced injury of the major salivary glands.
Valdés Olmos RA; Keus RB; Takes RP; van Tinteren H; Baris G; Hilgers FJ; Hoefnagel CA; Balm AJ
Cancer; 1994 Jun; 73(12):2886-93. PubMed ID: 8199984
[TBL] [Abstract][Full Text] [Related]
5. Amifostine for salivary glands in high-dose radioactive iodine treated differentiated thyroid cancer.
Ma C; Xie J; Chen Q; Wang G; Zuo S
Cochrane Database Syst Rev; 2009 Oct; 2009(4):CD007956. PubMed ID: 19821441
[TBL] [Abstract][Full Text] [Related]
6. Studies on the radioprotective potency of amifostine on salivary glands of rats during fractionated irradiation: acute and late effects.
Sagowski C; Wenzel S; Metternich FU; Kehrl W
Eur Arch Otorhinolaryngol; 2003 Jan; 260(1):42-7. PubMed ID: 12520356
[TBL] [Abstract][Full Text] [Related]
7. Effect of Amifostine to prevent radiotherapy-induced acute and late toxicity in head and neck cancer patients who had normal or mild impaired salivary gland function.
Veerasarn V; Phromratanapongse P; Suntornpong N; Lorvidhaya V; Sukthomya V; Chitapanarux I; Tesavibul C; Swangsilpa T; Khorprasert C; Shotelersuk K; Kongthanarat Y; Panichevaluk A; Chiewvit S; Pusuwan P; Aekmahachai M; Ratchadara S; Sirilipoche S; Saengsuda Y
J Med Assoc Thai; 2006 Dec; 89(12):2056-67. PubMed ID: 17214057
[TBL] [Abstract][Full Text] [Related]
8. Toxicity and compliance of subcutaneous amifostine in patients undergoing postoperative intensity-modulated radiation therapy for head and neck cancer.
Thorstad WL; Chao KS; Haughey B
Semin Oncol; 2004 Dec; 31(6 Suppl 18):8-12. PubMed ID: 15726516
[TBL] [Abstract][Full Text] [Related]
9. [Relation between uptake of 67Ga-citrate in salivary glands and irradiation doses].
Yoshida T; Akutsu T; Komatani A; Yamaguchi K
Kaku Igaku; 1993 Jun; 30(6):637-41. PubMed ID: 8345694
[TBL] [Abstract][Full Text] [Related]
10. Radioprotection of salivary glands by S-2-(3-aminopropylamino)-ethylphosphorothioic (amifostine) obtained in a rabbit animal model.
Bohuslavizki KH; Klutmann S; Jenicke L; Brenner W; Feyerabend B; Henze E; Clausen M
Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):181-6. PubMed ID: 10477022
[TBL] [Abstract][Full Text] [Related]
11. Radioprotective effect of amifostine in patients with head and neck squamous cell carcinoma.
Bourhis J; Rosine D
Semin Oncol; 2002 Dec; 29(6 Suppl 19):61-2. PubMed ID: 12577247
[TBL] [Abstract][Full Text] [Related]
12. Amifostine is a potent radioprotector of salivary glands in radioiodine therapy. Structural and ultrastructural findings.
Kutta H; Kampen U; Sagowski C; Brenner W; Bohuslavizki KH; Paulsen F
Strahlenther Onkol; 2005 Apr; 181(4):237-45. PubMed ID: 15827693
[TBL] [Abstract][Full Text] [Related]
13. Phase III randomized trial of amifostine as a radioprotector in head and neck cancer.
Brizel DM; Wasserman TH; Henke M; Strnad V; Rudat V; Monnier A; Eschwege F; Zhang J; Russell L; Oster W; Sauer R
J Clin Oncol; 2000 Oct; 18(19):3339-45. PubMed ID: 11013273
[TBL] [Abstract][Full Text] [Related]
14. [Side effects of postoperative radiochemotherapy with amifostine versus radiochemotherapy alone in head and neck tumors. Preliminary results of a prospective randomized trial].
Vacha P; Marx M; Engel A; Richter E; Feyerabend T
Strahlenther Onkol; 1999 Nov; 175 Suppl 4():18-22. PubMed ID: 10584135
[TBL] [Abstract][Full Text] [Related]
15. Oral candidiasis in head and neck cancer patients receiving radiotherapy with amifostine cytoprotection.
Nicolatou-Galitis O; Sotiropoulou-Lontou A; Velegraki A; Pissakas G; Kolitsi G; Kyprianou K; Kouloulias V; Papanikolaou I; Yiotakis I; Dardoufas K
Oral Oncol; 2003 Jun; 39(4):397-401. PubMed ID: 12676261
[TBL] [Abstract][Full Text] [Related]
16. In regard to Münter et Al. Changes in salivary gland function after radiotherapy of head and neck tumors measured by quantitative pertechnetate scintigraphy: comparison of intensity-modulated radiotherapy and conventional radiation therapy with and without amifostine. (Int j radiat oncol biol phys 2007;67:651-659).
Messerschmidt GL; Oleka N
Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1651-2; author reply 1652. PubMed ID: 18035221
[No Abstract] [Full Text] [Related]
17. [Reducing late toxicity with amifostine in fractionated irradiation of the rat salivary glands].
Sagowski C; Wenzel S; Jenicke L; Bohuslavizki KH; Kehrl W; Zywietz F; Roeser K
HNO; 2002 Sep; 50(9):822-8. PubMed ID: 12425136
[TBL] [Abstract][Full Text] [Related]
18. Radioprotection of salivary glands by amifostine in high-dose radioiodine therapy.
Bohuslavizki KH; Brenner W; Klutmann S; Hübner RH; Lassmann S; Feyerabend B; Lüttges J; Tinnemeyer S; Clausen M; Henze E
J Nucl Med; 1998 Jul; 39(7):1237-42. PubMed ID: 9669401
[TBL] [Abstract][Full Text] [Related]
19. [An evaluation of the clinical usefulness of amifostine (YM-08310), radioprotective agent. A double-blind placebo-controlled study. 1. Head and neck tumors].
Niibe H; Takahashi I; Mitsuhashi N; Miyaishi K; Itoh J; Maehara Y; Nakajima N; Suto H; Sakaino K; Matsuura S
Nihon Gan Chiryo Gakkai Shi; 1985 Jun; 20(5):984-93. PubMed ID: 2997351
[No Abstract] [Full Text] [Related]
20. [Current status of prevention and management of radiation-induced xerostomia].
Ma DY; Qiu WL; Zhang CP
Zhonghua Kou Qiang Yi Xue Za Zhi; 2010 Feb; 45(2):121-3. PubMed ID: 20368009
[No Abstract] [Full Text] [Related]
[Next] [New Search]